Clinical Trial Update: The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis

View source ↗

Summary

A clinical trial update examining how IL-17–producing regulatory T cells may promote immune tolerance in liver transplant recipients who have aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Liver Transplantation, Aspergillus | Status: UNKNOWN